Bethesda, MDNCT03835767Now EnrollingIRB Ready

Milk and/or Peanut Allergy Clinical Trial in Bethesda, MD

Access cutting-edge milk and/or peanut allergy treatment through this phase 2 clinical trial at a research site in Bethesda. Study-provided care at no cost to qualified participants.

Sponsored by National Institute of Allergy and Infectious Diseases (NIAID)

Quick Self-Assessment

See if you qualify for this Bethesda location

Preparing your pre-screening questions…

Expert Care in Bethesda

Access milk and/or peanut allergy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related milk and/or peanut allergy treatment provided free

Apply for This Bethesda Location

Check if you qualify for this milk and/or peanut allergy clinical trial in Bethesda, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Bethesda

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Bethesda site if eligible
  4. 4Begin participation

About This Milk and/or Peanut Allergy Study in Bethesda

Background: Atopic dermatitis (AD), also called eczema, makes skin dry, red, and itchy. People with AD are more likely to get a food allergy than people without AD. But some food allergy tests are not always accurate in people with AD. Researchers want to study if people are truly allergic to milk and/or peanuts. Objectives: To improve the ways doctors test for food allergy in people with AD. Eligibility: People ages 3-21 who have had AD; have a high total IgE level (an allergic antibody); might have a milk and/or peanut allergy; and are currently enrolled in another NIH study Design: Participants will be screened under another protocol. Participants will have a physical exam, blood tests, and medical history. Participants will breathe into a plastic device that measures lung strength. Participants may get a small plastic tube inserted in their arm. Participants who have not had an allergic reaction to food in the past 3 years will do 1 or more oral food challenge (OFCs) depending on their allergies. They will eat a little bit of the food they might be allergic to. They will be watched for a reaction. If they have one, they will know for sure they are allergic. They may keep eating bigger portions of the food until they either have a reaction or finish all the food. In some OFCs, participants will get a placebo food. OFCs will last a few hours or 2 days. Participants will repeat all tests at each OFC. Participation can last up to 12 months. ...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Who Can Participate

Inclusion Criteria

Individuals must meet all of the following criteria to be eligible for study participation:
Aged 3-21 years.
Currently enrolled on study 15-I-0162, "Natural History and Genetics of Food Allergy and Related Conditions."
Has a total serum IgE level \>= 900 kU/L at time of screening.
Has a history of AD based on self-report or physician assessment.
Willing to undergo an oral food challenge to both placebo and test food.
Willing to allow storage of blood samples for future use in medical research.
Willing to allow genetic testing to be conducted on blood samples.
Has a primary care physician or other physician who will manage all health conditions related or unrelated to the study objectives.
Be willing to discontinue omalizumab or dupilumab within 6 months of a food challenge,and antihistamines and oral steroids prior to a food challenge, as these drugs might interfere with the oral food challenge procedure. Use of topical steroids will be allowed
Able to provide informed consent.

Exclusion Criteria

CRITIERIA: Individuals meeting any of the following criteria will be excluded from study participation:
Known genetic disorder that causes an elevation in total IgE level or one that could affect the severity of an anaphylactic response.
Known cardiac disease.
Current use of a beta-blocker.
Active eosinophilic gastrointestinal (GI) disorder including eosinophilic esophagitis, currently symptomatic, unless they are currently on treatment and have had a negative esophageal biopsy via endoscopy within at least the past 18 months, and/or unless the study food is already in the participants diets.
Any chronic medical condition requiring long-term use of oral steroids.
Current or recent (within previous 6 months) use of omalizumab or dupilumab.
Any condition that, in the opinion of the investigator, contraindicates participation in this study. Co-enrollment guidelines: Co-enrollment in other trials is restricted, other than enrollment on observational studies. Consideration for co-enrollment in trials evaluating the use of a licensed medication will require the approval of the principal investigator. Study staff should be notified of co-enrollment on any other protocol as it may require the approval of the principal investigator.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Bethesda?

Yes, this clinical trial (NCT03835767) has an active research site in Bethesda, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Milk and/or Peanut Allergy Treatment Options in Bethesda, MD

If you're searching for milk and/or peanut allergy treatment options in Bethesda, MD, this clinical trial (NCT03835767) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Bethesda research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced milk and/or peanut allergy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all milk and/or peanut allergy clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Bethesda, MD

See all leukemia clinical trials recruiting in Bethesda — not just this study.

Browse Leukemia Trials in Bethesda →

Browse More Trials by Condition

Leukemia TrialsHeart Attack TrialsPulmonary Embolism TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Bethesda?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Bethesda, MD